KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Change in Cash (2016 - 2026)

Pfizer has reported Change in Cash over the past 18 years, most recently at $563.0 million for Q1 2026.

  • Quarterly Change in Cash rose 50.13% to $563.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $279.0 million through Mar 2026, up 108.76% year-over-year, with the annual reading at $91.0 million for FY2025, 105.03% up from the prior year.
  • Change in Cash was $563.0 million for Q1 2026 at Pfizer, up from -$196.0 million in the prior quarter.
  • Over five years, Change in Cash peaked at $1.8 billion in Q2 2023 and troughed at -$2.1 billion in Q1 2024.
  • The 5-year median for Change in Cash is $213.0 million (2025), against an average of -$84.1 million.
  • Year-over-year, Change in Cash surged 3626.67% in 2022 and then plummeted 429.91% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$646.0 million in 2022, then soared by 51.08% to -$316.0 million in 2023, then plummeted by 458.54% to -$1.8 billion in 2024, then soared by 88.9% to -$196.0 million in 2025, then soared by 387.24% to $563.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Change in Cash are $563.0 million (Q1 2026), -$196.0 million (Q4 2025), and -$301.0 million (Q3 2025).